Assessment of concentration and penetration depth of cisplatin in human lung tissue after decortication and hyperthermic exposure
Authors:
Open Access
- 1 June 2021
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (11) , 953
Abstract
Background: Hyperthermic perfusion of the pleural cavity with cisplatin after pleurectomy/decortication is an additional therapeutic option to reduce local relapse of malignant pleural tumours. Although there are data on the clinical effect, only little is known about the local impact on human lung tissue by cisplatin. The objective of this experimental study is to evaluate both the concentration and the penetration depth of cisplatin in human lung tissue after normothermic and hyperthermic exposure under ex-vivo-in-vitro conditions. Methods: This study was approved by the local ethics committee. In total, 46 patients underwent elective lobectomy and wedge resections were taken from the resected lobes. A decortication of the visceral pleura was performed under ex-vivo conditions, and the tissue samples were incubated with cisplatin (c =0.05 mg/mL) at 37, 42 or 45 °C for 60 minutes. Then the mass concentration of platinum was measured with flameless atomic absorption spectroscopy and then converted into cisplatin concentration. In addition, the current data were compared with previous data of our working group (42 °C, without decortication). Results: The overall maximum penetration depth was 7.5 mm due to limitations of our methods. The functional maximum penetration depth did not vary with temperature (P=0.243) but by decortication (PConclusions: Decortication of the visceral pleura increases the cisplatin concentration in the lung tissue. Therefore, it possibly reduces the likelihood of a local relapse. An increase of temperature did not show any effect.Keywords
This publication has 22 references indexed in Scilit:
- Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resectionThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignanciesJournal of Surgical Oncology, 2013
- Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: An in vitro evaluationThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: Role of inhibitor of apoptosis proteins (IAPs) and caspasesInternational Journal of Oncology, 2012
- Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest GroupJournal of Thoracic Oncology, 2011
- Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective studyThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialThe Lancet, 2008
- Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patientsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: A feasibility and pharmacokinetic studyThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape ProvinceOccupational and Environmental Medicine, 1960